Demant A/S (CPH:DEMANT)
Denmark · Delayed Price · Currency is DKK 216.40
+3.20 (1.50%)
At close: Dec 5, 2025
Demant Market Cap
Demant has a market cap or net worth of 46.1 billion as of December 5, 2025. Its market cap has decreased by -20.04% in one year.
Market Cap
46.10B
Enterprise Value
61.21B
Revenue
22.59B
Ranking
n/a
PE Ratio
17.31
Stock Price
216.40
Market Cap Chart
Since November 21, 1995, Demant's market cap has increased from 2.12B to 46.10B, an increase of 2,075.44%. That is a compound annual growth rate of 10.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 46.10B | -19.86% |
| Dec 30, 2024 | 57.52B | -10.34% |
| Dec 29, 2023 | 64.15B | 51.17% |
| Dec 30, 2022 | 42.43B | -47.09% |
| Dec 30, 2021 | 80.20B | 39.08% |
| Dec 30, 2020 | 57.66B | 12.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.35T |
| Coloplast | 130.40B |
| Genmab | 124.62B |
| ALK-Abelló | 51.14B |
| H. Lundbeck | 41.69B |
| Zealand Pharma | 34.69B |
| Ambu A/S | 23.19B |
| Embla Medical | 15.47B |